Concord Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|
| Revenue | 258.95 | 320.21 | 226.11 |
| Operating Expense | 146.27 | 173.50 | 134.52 |
| Net Profit | 74.09 | 98.70 | 58.24 |
| Net Profit Margin | 28.61 | 30.82 | 25.76 |
| Earning Per Share | 7.08 | 9.43 | 5.57 |
| EBIDTA | 111.14 | 146.17 | 91.05 |
| Effective Tax Rate | 21.02 | 23.22 | 21.17 |
| Particulars | Dec 2024 |
|---|---|
| Revenue | 258.95 |
| Operating Expense | 146.27 |
| Net Profit | 74.09 |
| Net Profit Margin | 28.61 |
| Earning Per Share | 7.08 |
| EBIDTA | 111.14 |
| Effective Tax Rate | 21.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,016.94 | 853.17 | 712.93 |
| Operating Expenses Annual | 585.38 | 509.88 | 439.66 |
| Operating Profit Annual | 465.34 | 378.60 | 296.69 |
| Interest Annual | 2.55 | 4.51 | 5.48 |
| Depreciation | 51.56 | 49.54 | 45.56 |
| Net Profit Annual | 304.73 | 238.13 | 178.57 |
| Tax Annual | 104.46 | 81.93 | 62.59 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,016.94 |
| Operating Expenses Annual | 585.38 |
| Operating Profit Annual | 465.34 |
| Interest Annual | 2.55 |
| Depreciation | 51.56 |
| Net Profit Annual | 304.73 |
| Tax Annual | 104.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.50 | 0.67 | 5.14 |
| Cash Flow from Operations | 265.47 | 246 | 207.47 |
| Cash Flow from Investing | -154.61 | -157.95 | -111.79 |
| Cash Flow from Financing | -99.21 | -85.22 | -100.16 |
| Cash Flow at the End | 15.14 | 3.50 | 0.67 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.50 |
| Cash Flow from Operations | 265.47 |
| Cash Flow from Investing | -154.61 |
| Cash Flow from Financing | -99.21 |
| Cash Flow at the End | 15.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 45.82 | 44.45 | 41.71 |
| PBIT Margin (%) | 40.55 | 38.12 | 34.69 |
| PBT Margin (%) | 27.80 | 30.76 | 29.03 |
| Net PROFIT Margin (%) | 29.97 | 27.91 | 25.05 |
| Return On Networth / Equity (%) | 21.63 | 19.85 | 16.95 |
| Return On Networth /Employed (%) | 28.81 | 26.05 | 21.86 |
| Return On Assets (%) | 21.28 | 18.98 | 15.78 |
| Total Debt / Equity (X) | 0.01 | 0.04 | 0.07 |
| Asset Turnover Ratio (%) | 0.71 | 0.68 | 0.63 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 45.82 |
| PBIT Margin (%) | 40.55 |
| PBT Margin (%) | 27.80 |
| Net PROFIT Margin (%) | 29.97 |
| Return On Networth / Equity (%) | 21.63 |
| Return On Networth /Employed (%) | 28.81 |
| Return On Assets (%) | 21.28 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 575.32 | 592.98 | 572.98 |
| Total Current Assets Annual | 896.23 | 727.70 | 632.67 |
| Non Current Assets Annual | 803.08 | 786.95 | 680.79 |
| Total Shareholders Funds Annual | 1,525.25 | 1,291.98 | 1,107.16 |
| Total Assets Annual | 1,699.32 | 1,514.65 | 1,313.46 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 575.32 |
| Total Current Assets Annual | 896.23 |
| Non Current Assets Annual | 803.08 |
| Total Shareholders Funds Annual | 1,525.25 |
| Total Assets Annual | 1,699.32 |
EPS (INR)
Expected
7.26
Reported
7.26
Surprise
0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
